Celltrion HealthCare France
France-based affiliate of an international biopharmaceutical group focused on development, manufacturing and commercialization of biologic therapies and biosimilars. Stated activities include biologics R&D, GMP-aligned manufacturing and scale-up, regulatory dossier preparation aligned with EMA/FDA guidance, clinical research and post-marketing safety monitoring, global distribution across multiple countries, and patient support for self-administration and infusion products. Operations emphasize regulatory compliance, quality management and EU data protection (GDPR).
Industries
N/A
Nr. of Employees
small (1-50)
Products
Truxima (rituximab) — infusion solution
Monoclonal antibody biologic available as a solution for dilution and intravenous infusion in multiple strengths/dosages.
Omlyclo (omalizumab) — prefilled syringe and pen
Anti-IgE biologic provided as prefilled syringes and prefilled pens with patient administration materials and instructional media.
Stoboclo (denosumab) — prefilled syringe
Denosumab biologic supplied as prefilled syringes with automatic needle protection.
Yuflyma (adalimumab) — prefilled syringe and pen
TNF-alpha inhibitor biologic available in prefilled syringes and prefilled pens; patient guides and instructional videos provided.
Herzuma (trastuzumab) — powder for infusion
HER2-targeting monoclonal antibody supplied as powder for reconstitution and infusion in multiple vial sizes.
Steqeyma (ustekinumab) — injectable and infusion formulations
Interleukin-targeting biologic provided as prefilled syringes, injection solutions and infusion formulations with patient administration materials.
Truxima (rituximab) — infusion solution
Monoclonal antibody biologic available as a solution for dilution and intravenous infusion in multiple strengths/dosages.
Omlyclo (omalizumab) — prefilled syringe and pen
Anti-IgE biologic provided as prefilled syringes and prefilled pens with patient administration materials and instructional media.
Stoboclo (denosumab) — prefilled syringe
Denosumab biologic supplied as prefilled syringes with automatic needle protection.
Yuflyma (adalimumab) — prefilled syringe and pen
TNF-alpha inhibitor biologic available in prefilled syringes and prefilled pens; patient guides and instructional videos provided.
Herzuma (trastuzumab) — powder for infusion
HER2-targeting monoclonal antibody supplied as powder for reconstitution and infusion in multiple vial sizes.
Steqeyma (ustekinumab) — injectable and infusion formulations
Interleukin-targeting biologic provided as prefilled syringes, injection solutions and infusion formulations with patient administration materials.
Expertise Areas
- Biosimilar development
- GMP biologics manufacturing
- Injectable and infusion formulation
- Clinical research and pharmacovigilance
Key Technologies
- Monoclonal antibody biomanufacturing
- Prefilled syringe and autoinjector delivery systems
- Intravenous infusion formulation and lyophilized powder reconstitution
- GMP manufacturing processes